NCT00032474View on ClinicalTrials.gov

Ginkgo Biloba Extract and the Insulin Resistance Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

May 31, 2005

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Ginkgo biloba extract

Trial Locations (1)

78229

University of Texas Health Sciences Center, San Antonio

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00032474 - Ginkgo Biloba Extract and the Insulin Resistance Syndrome | Biotech Hunter | Biotech Hunter